Sinotherapeutics Inc. (SHA:688247)
China · Delayed Price · Currency is CNY 9.27
-0.12 (-1.28%)
Sep 9, 2026, 4:00 PM EDT
Sinotherapeutics Revenue
Sinotherapeutics had revenue of 96.61M CNY in the quarter ending June 30, 2026, a decrease of -12.71%. This brings the company's revenue in the last twelve months to 418.12M, down -18.53% year-over-year. In the year 2025, Sinotherapeutics had annual revenue of 446.57M, down -12.71%.
Revenue (ttm)
418.12M
Revenue Growth
-18.53%
P/S Ratio
9.95
Revenue / Employee
1.31M
Employees
319
Market Cap
4.16B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 446.57M | -65.05M | -12.71% |
| Dec 31, 2024 | 511.62M | 211.75M | 70.61% |
| Dec 31, 2023 | 299.87M | 52.31M | 21.13% |
| Dec 31, 2022 | 247.56M | -67.91M | -21.53% |
| Dec 31, 2021 | 315.47M | -3.69M | -1.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Jinling Pharmaceutical Company | 3.18B |
| Jinhe Biotechnology CO., LTD. | 2.94B |
| Qianjiang Yongan Pharmaceutical | 979.49M |
| Shandong Wohua Pharmaceutical | 784.94M |
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD | 737.90M |
| Newland Pharmaceutical | 710.55M |
| Shanghai Xiao Fang Pharmaceutical | 541.90M |
| Zhongzhu Healthcare Holding Co.,Ltd | 533.88M |